Morning Market Movers

IsoRay

shares gained 26.67% to $3.23 as the company announced first pediatric Cesium-131 seeded mesh treatment for metastatic Wilms tumor. BG Medicine

climbed 24.25% to $2.10 after the company reported narrower-than-expected Q4 loss and reported the issuance of patent covering Galectin-3. Synta Pharmaceuticals

shares jumped 12% to $5.32 on positive interim results from the ENCHANT-1 trial of ganetespib in metastatic breast cancer. Magnegas

gained 11.20% to $1.39 after the company reported that it has been selected for four demolition projects. Burlington Stores

shares jumped 11.04% to $28.76 on Q4 results. Burlington Stores reported its Q4 earnings of $1.07 per share, versus analysts' estimates of $1.03 per share. Sinovac Biotech

climbed 7.69% to $7.42 after the company reported unaudited Q4 results. Sinovac Biotech posted its quarterly net income of $5.8 million, or $0.10 per share, versus a year-ago net loss of $4.6 million, or $0.08 per share. Herman Miller

shares jumped 6.58% to $30.60 after the company reported in-line FQ3 adjusted earnings. The company expected Q4 earnings of $0.43 to $0.47 per share on revenue of $485 million to $505 million. However, analysts were projecting earnings of $0.43 per share on revenue of $487.5 million. Eagle Pharmaceuticals

shares jumped 4.01% to $15.06 on announcement of the NDA for Ryanodex being accepted by the US FDA with a priority review.